The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper ...

A ketamine-based nasal spray is officially the first and only ... The FDA first approved the Johnson & Johnson drug, called Spravato (esketamine), for some cases of depression in 2019, but it ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

But you should take doses of the nasal corticosteroid or nasal decongestant at least 1 hour before you receive a dose of Spravato. In studies of Spravato, the nasal decongestant oxymetazoline was ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient ...

The UK agency declined to recommend NHS funding for Spravato (esketamine) nasal spray in 2020 – following ... convinced by the clinical data for the drug and believed it was not cost-effective.

Stella Mental Health in Westmont specializes in medication management, Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion ...